The global drug screening market size reached a value of US$ 5.42 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 9.36 Billion by 2027, exhibiting a CAGR of 9.30% during 2022-2027.
Drug screening includes the analysis of urine, hair, blood, breath, sweat, or oral fluid specimens using different methods. It is used to detect the presence of drugs in the body and for various other purposes, including clinical care, legal prosecution, occupational health, rehabilitation, and risk management. Apart from this, drug screening also finds extensive application in assessing abuse potential and adherence among patients receiving opioid therapy.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/drug-screening-market/requestsample
Drug Screening Market Trends and Drivers:
The market is primarily driven by the implementation of stringent regulations by governments of numerous countries regarding random drug screening for personnel in law enforcement, national security, military, and public health.
In addition, the rising incidences of fatal road accidents are escalating the demand for drug screening to ensure road safety. Moreover, drug screening is widely conducted during sports and athletic competitions to detect performance-enhancing drugs, and human growth hormone (HGH), in professional athletes.
This, coupled with the introduction of innovative product variants such as point-of-care testing devices for workplace drug testing, is further contributing to the market growth.
Global Drug Screening Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Abbott Laboratories, Alfa Scientific Designs Inc., Bio-Rad Laboratories Inc., Drägerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings, Lifeloc Technologies Inc., Omega Laboratories Inc., OraSure Technologies Inc., Psychemedics Corporation, Quest Diagnostics Incorporated, Siemens AG and Thermo Fisher Scientific Inc.
Inquire Before Buying : https://www.imarcgroup.com/request?type=report&id=5624&flag=F
The report has segmented the market on the basis of region, product and service, sample type and end user.
Breakup by Product and Service:
Rapid Testing Devices
Urine Testing Devices
Oral Fluid Testing Devices
Sample Collection Cups
Calibrators and Controls
Breakup by Sample Type:
Oral Fluid Samples
Breakup by End User:
Drug Testing Laboratories
Drug Treatment Centers
Pain Management Centers
Criminal Justice System and Law Enforcement Agencies
Breakup by Region:
North America: (United States, Canada)
Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
Latin America: (Brazil, Mexico, Others)
Middle East and Africa
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
Market Performance (2016-2021)
Market Outlook (2022- 2027)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800